Home » Stocks » PBIO

Pressure BioSciences Inc. (PBIO)

Stock Price: $2.30 USD -0.19 (-7.63%)
Updated Feb 26, 2021 3:42 PM EST - Market closed
Market Cap 8.94M
Revenue (ttm) 1.34M
Net Income (ttm) -16.91M
Shares Out 3.61M
EPS (ttm) -5.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $2.30
Previous Close $2.49
Change ($) -0.19
Change (%) -7.63%
Day's Open 2.35
Day's Range 2.06 - 2.49
Day's Volume 10,518
52-Week Range 1.19 - 4.49

News

There are no news available yet.

About PBIO

Pressure BioSciences develops pressure cycling technology (PCT) solutions in North America, Europe, and Asia. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumab... [Read more...]

Industry
Medical Devices
IPO Date
Oct 31, 1996
CEO
Richard T. Schumacher
Employees
14
Stock Exchange
OTCMKTS
Ticker Symbol
PBIO
Full Company Profile

Financial Performance

In 2019, PBIO's revenue was $1.81 million, a decrease of -26.36% compared to the previous year's $2.46 million. Losses were -$11.66 million, 20.2% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for PBIO is 1.57, which is a decrease of -31.74% from the latest price.

Price Target
$1.57
(-31.74% downside)